Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19063-55-9

Post Buying Request

19063-55-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19063-55-9 Usage

Synthesis Reference(s)

Tetrahedron, 62, p. 6918, 2006 DOI: 10.1016/j.tet.2006.04.080

Check Digit Verification of cas no

The CAS Registry Mumber 19063-55-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,0,6 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 19063-55:
(7*1)+(6*9)+(5*0)+(4*6)+(3*3)+(2*5)+(1*5)=109
109 % 10 = 9
So 19063-55-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H5BrO2/c10-7-2-3-8-6(5-7)1-4-9(11)12-8/h1-5H

19063-55-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-Bromochromen-2-one

1.2 Other means of identification

Product number -
Other names 6-bromo-2H-chromen-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19063-55-9 SDS

19063-55-9Relevant articles and documents

Dicyanovinylcoumarin as a turn-on fluorescent sensor for cyanide ion

Reddy, T. Sheshashena,Choi, Myung-Seok

, p. 108 - 114 (2018)

Dicyanovinylcoumarin chemosensors (4a, 4b and 4c) were designed and synthesized by the Knoevenagel condensation reaction. The electronic absorption and emission spectra of the dicyanovinylcoumarin isomers exhibited red shifted absorption and less emission as compared to their precursor's coumarin aldehydes. The sensing behavior of dicyanovinylcoumarin isomers were studied for different anions. In these dicyanovinylcoumarin isomers, the 7-substituted isomer shows high selectivity towards CN? in the presence of other F?, Cl?, Br?, I?, ClO4?, HSO4? and NO2? ions. The effect of CN? on the structure of dicyanovinylcoumarin isomer was studied by performing DFT calculations. The theoretical calculations show strong agreement with the experimental results. The detection limit for CN? were found to be 1.14 × 10?8 M for 7-substitued dicyanovinylcoumarin isomer 4b.

Synthesis of analogues of natural coumarins and coumarinolignans

Ismailova

, p. 292 - 296 (2005)

3-Aryl-4H-coumarins with the 1,3-benzodioxol, 1,4-benzodioxane, and 1,5-benzodioxepane moieties were synthesized by modified methods.

Polyphosphoric acid-promoted synthesis of coumarins lacking substituents at positions 3 and 4

Yang, Li-Shou,Wang, Yu,Wang, En-Hua,Yang, Jan,Pan, Xiong,Liao, Xiu,Yang, Xiao-Sheng

, p. 1 - 6 (2020)

Coumarins have recently emerged as a hot topic of research due to their diverse pharmacological properties. This work described a method for the synthesis of 3,4-diunsubstituted coumarins promoted by polyphosphoric acid (PPA) from salicylaldehydes and acetic anhydride. Various coumarins were produced in good to excellent yields.

Fe(III)-Catalyzed Decarboxylative C3-Difluoroarylmethylation of Coumarins with α,α-Difluoroarylacetic Acids

Chen, Zhiwei,Bai, Xiang,Sun, Jie,Xu, Yicheng

supporting information, p. 7674 - 7682 (2020/07/15)

A facile Fe(III)-catalyzed oxidative decarboxylative radical coupling reaction of α,α-difluoroarylacetic acids with coumarins has been developed. This transformation, which provides a series of C-3 difluoroarylmethylated coumarins containing various functional groups in moderate-to-good yields, features easily accessible starting materials and operational simplicity.

BIPHENYL COMPOUND AS CCR2/CCR5 RECEPTOR ANTAGONIST

-

Paragraph 0192, (2019/11/21)

Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19063-55-9